170 related articles for article (PubMed ID: 26889431)
1. Niacin in patients with chronic kidney disease: Is it effective and safe?
Park CW
Kidney Res Clin Pract; 2013 Mar; 32(1):1-2. PubMed ID: 26889431
[No Abstract] [Full Text] [Related]
2. Niacin improves renal lipid metabolism and slows progression in chronic kidney disease.
Cho KH; Kim HJ; Kamanna VS; Vaziri ND
Biochim Biophys Acta; 2010 Jan; 1800(1):6-15. PubMed ID: 19878707
[TBL] [Abstract][Full Text] [Related]
3. Lowering Expectations with Niacin Treatment for CKD-MBD.
Drüeke TB; Massy ZA
Clin J Am Soc Nephrol; 2018 Jan; 13(1):6-8. PubMed ID: 29208625
[No Abstract] [Full Text] [Related]
4. Niacin and related compounds for treating hyperphosphatemia in dialysis patients.
Berns JS
Semin Dial; 2008; 21(3):203-5. PubMed ID: 18363600
[TBL] [Abstract][Full Text] [Related]
5. The Effect of Extended Release Niacin on Markers of Mineral Metabolism in CKD.
Malhotra R; Katz R; Hoofnagle A; Bostom A; Rifkin DE; Mcbride R; Probstfield J; Block G; Ix JH
Clin J Am Soc Nephrol; 2018 Jan; 13(1):36-44. PubMed ID: 29208626
[TBL] [Abstract][Full Text] [Related]
6. Effects of low-dose niacin on dyslipidemia and serum phosphorus in patients with chronic kidney disease.
Jin Kang H; Kim DK; Mi Lee S; Han Kim K; Hee Han S; Hyun Kim K; Eun Kim S; Ki Son Y; An WS
Kidney Res Clin Pract; 2013 Mar; 32(1):21-6. PubMed ID: 26889433
[TBL] [Abstract][Full Text] [Related]
7. Niacin ameliorates kidney warm ischemia and reperfusion injury-induced ventricular dysfunction and oxidative stress and disturbance in mitochondrial metabolism in rats.
Tai ST; Fu YH; Yang YC; Wang JJ
Transplant Proc; 2015 May; 47(4):1079-82. PubMed ID: 26036524
[TBL] [Abstract][Full Text] [Related]
8. Effect of niacin on FGF23 concentration in chronic kidney disease.
Rao M; Steffes M; Bostom A; Ix JH
Am J Nephrol; 2014; 39(6):484-90. PubMed ID: 24854458
[TBL] [Abstract][Full Text] [Related]
9. Niacin and Chronic Kidney Disease.
Taketani Y; Masuda M; Yamanaka-Okumura H; Tatsumi S; Segawa H; Miyamoto K; Takeda E; Yamamoto H
J Nutr Sci Vitaminol (Tokyo); 2015; 61 Suppl():S173-5. PubMed ID: 26598845
[TBL] [Abstract][Full Text] [Related]
10. Niacin ameliorates oxidative stress, inflammation, proteinuria, and hypertension in rats with chronic renal failure.
Cho KH; Kim HJ; Rodriguez-Iturbe B; Vaziri ND
Am J Physiol Renal Physiol; 2009 Jul; 297(1):F106-13. PubMed ID: 19420110
[TBL] [Abstract][Full Text] [Related]
11. Niacin and progression of CKD.
Streja E; Kovesdy CP; Streja DA; Moradi H; Kalantar-Zadeh K; Kashyap ML
Am J Kidney Dis; 2015 May; 65(5):785-98. PubMed ID: 25708553
[TBL] [Abstract][Full Text] [Related]
12. Safety and tolerability of simvastatin plus niacin in patients with coronary artery disease and low high-density lipoprotein cholesterol (The HDL Atherosclerosis Treatment Study).
Zhao XQ; Morse JS; Dowdy AA; Heise N; DeAngelis D; Frohlich J; Chait A; Albers JJ; Brown BG
Am J Cardiol; 2004 Feb; 93(3):307-12. PubMed ID: 14759379
[TBL] [Abstract][Full Text] [Related]
13. Is combined lipid-regulating therapy safe and feasible for the very old patients with mixed dyslipidemia?
Zou X; Si QJ
J Geriatr Cardiol; 2013 Dec; 10(4):349-54. PubMed ID: 24454328
[TBL] [Abstract][Full Text] [Related]
14. Niacin as potential treatment for dyslipidemia and hyperphosphatemia associated with chronic renal failure: the need for clinical trials.
Ahmed MH
Ren Fail; 2010 Jun; 32(5):642-6. PubMed ID: 20486851
[TBL] [Abstract][Full Text] [Related]
15. The benefits of niacin in atherosclerosis.
Tavintharan S; Kashyap ML
Curr Atheroscler Rep; 2001 Jan; 3(1):74-82. PubMed ID: 11123852
[TBL] [Abstract][Full Text] [Related]
16. Niacin, lipids, and heart disease.
Malik S; Kashyap ML
Curr Cardiol Rep; 2003 Nov; 5(6):470-6. PubMed ID: 14558989
[TBL] [Abstract][Full Text] [Related]
17. [Efficacy and safety of immediate-release niacin in patients with ischemic cardiopathy. Experience of the Instituto Nacional de Cardiología "Ignacio Chávez"].
Morato Hernández ML; Ichazo Cerro MS; Alvarado Vega AG; Zamora González J; Cardoso Saldaña GC; Posadas Romero C
Arch Inst Cardiol Mex; 2000; 70(4):367-76. PubMed ID: 11075282
[TBL] [Abstract][Full Text] [Related]
18. Demand for Water-Soluble Vitamins in a Group of Patients with CKD versus Interventions and Supplementation-A Systematic Review.
Kędzierska-Kapuza K; Szczuko U; Stolińska H; Bakaloudi DR; Wierzba W; Szczuko M
Nutrients; 2023 Feb; 15(4):. PubMed ID: 36839219
[TBL] [Abstract][Full Text] [Related]
19. Extended-release niacin/laropiprant lowers serum phosphorus concentrations in patients with type 2 diabetes.
Bostom AG; Maclean AA; Maccubbin D; Tipping D; Giezek H; Hanlon WA
J Clin Lipidol; 2011; 5(4):281-7. PubMed ID: 21784373
[TBL] [Abstract][Full Text] [Related]
20. Niacin as a component of combination therapy for dyslipidemia.
Miller M
Mayo Clin Proc; 2003 Jun; 78(6):735-42. PubMed ID: 12934785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
